The Substantial Clinical Benefit Threshold for SRS-22R Domains After Surgical Treatment of Adult Spinal Deformity
-
Add time:08/07/2019 Source:sciencedirect.com
Study DesignLongitudinal cohort.
We also recommend Trading Suppliers and Manufacturers of (22R)-2α,3α,14,20,22-Pentahydroxy-5β-cholest-7-en-6-one (cas 19338-77-3). Pls Click Website Link as below: cas 19338-77-3 suppliers
Prev:SRS-22R Minimum Clinically Important Difference and Substantial Clinical Benefit After Adult Lumbar Scoliosis Surgery
Next:Converting Scoliosis Research Society-24 to Scoliosis Research Society-22r in a Surgical-Range, Medical/Interventional Adolescent Idiopathic Scoliosis Patient Cohort) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- IL-22R, IL-10R2, and IL-22BP Binding Sites Are Topologically Juxtaposed on Adjacent and Overlapping Surfaces of IL-2208/09/2019
- Converting Scoliosis Research Society-24 to Scoliosis Research Society-22r in a Surgical-Range, Medical/Interventional Adolescent Idiopathic Scoliosis Patient Cohort08/08/2019
- SRS-22R Minimum Clinically Important Difference and Substantial Clinical Benefit After Adult Lumbar Scoliosis Surgery08/06/2019
- Age variation in the minimum clinically important difference in SRS-22r after surgical treatment for adult spinal deformity – A single institution analysis in Japan08/05/2019
- Reliability and Validity Testing of a Danish Translated Version of the Scoliosis Research Society Instrument–22 Revised (SRS-22R)08/04/2019
- The minimum detectable measurement difference for the scoliosis research society-22r in adolescent idiopathic scoliosis: a comparison with the minimum clinically important difference08/03/2019
- Cultural Variations in the Minimum Clinically Important Difference Thresholds for SRS-22R After Surgery for Adult Spinal Deformity08/02/2019
